Pancreatic cancer vaccine shows promise

New mRNA vaccine shows promise against pancreatic cancer, may extend life by 10 years
In a significant development for pancreatic cancer treatment, a phase 1 clinical trial has highlighted the potential of personalized mRNA vaccines to treat the deadly disease. This research comes at a critical time,
Vaccine targeting pancreatic cancer shows promise in new study of clinical trial
A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage pancreatic cancer patients.
Pancreatic cancer vaccine showing promise in early trial
Pancreatic cancer is the 10th deadliest form of cancer in the United States, according to the National Cancer Institute.
Vaccine shows promise for pancreatic cancer, study finds
Adding a personalized mRNA vaccine to standard treatment could offer new hope for pancreatic cancer patients, a small yet promising study from Memorial Sloan Kettering Cancer Center.
A Vaccine For Pancreatic Cancer Continues To Show Promise
In a small trial, nearly half of pancreatic cancer patients who received an mRNA vaccine for the disease had no relapse three years later.
Experimental vaccine for common cancer shows potential in clinical trial
A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study co-author Dr. Vinod Balachandran talks about the impact on future cancer care.
New biomarker panel shows promise for early detection of pancreatic cancer
The discovery of a 'biomarker panel' could have a profound impact on the ability to identify patients at risk of developing PC at an earlier stage.
Can mRNA vaccines help in the fight against pancreatic cancer?
There is new hope in the fight against pancreatic cancer after early trials showed that personalized mRNA vaccines can target and reduce malignant tumors. NBC News medical contributor Dr. Kavita Patel reports on the vaccine’s success against pancreatic cancer,
Trial shows promise of mRNA vaccines in treating pancreatic cancer
A recent study found that mRNA-based vaccines may help to delay the recurrence of pancreatic cancer by generating long-lasting immune responses. The phase 1 trial results, published Feb. 19 in Nature,
New Blood Test Could Detect Pancreatic Cancer Earlier
A new blood-based test could diagnose pancreatic cancer much earlier, improving outcomes for people with the disease.
Rolling Out1d
5 silent signs your body is masking pancreatic cancer
Discover why pancreatic cancer's warning signs often go unnoticed, masquerading as everyday health issues, learn the crucial red flags that shouldn't be ignored ...
Daily Herald1d
Is there a connection between prediabetes and pancreatic cancer?
Q: I just learned I have prediabetes. I also learned that a lot of people with pancreatic cancer have trouble with blood ...
Medscape3d
Identifying Pancreatic Cancer Remains Elusive. Here’s Why.
The symptoms of pancreatic cancer can be nonspecific, which means identifying the disease is often a challenge.
The Scientist11d
A Novel Three-in-One Pancreatic Organoid
An innovative organoid model mirrors the pancreas' complexity, generating all three key cell types to explore development and ...